hrcak mascot   Srce   HID

Original scientific paper
https://doi.org/10.2478/acph-2014-0022

Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP

JAN MUSELIK ; Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, 612 42 Brno
ALEŠ FRANC ; Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, 612 42 Brno
PETR DOLEŽEL ; Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, 612 42 Brno
ROMAN GONĚC ; Masaryk Memorial Cancer Institute, 612 42 Brno
ANNA KRONDLOVÁ ; Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, 612 42 Brno
IVANA LUKÁŠOVÁ ; Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, 612 42 Brno

Fulltext: english, pdf (453 KB) pages 355-367 downloads: 6.851* cite
APA 6th Edition
MUSELIK, J., FRANC, A., DOLEŽEL, P., GONĚC, R., KRONDLOVÁ, A. & LUKÁŠOVÁ, I. (2014). Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP. Acta Pharmaceutica, 64 (3), 355-367. https://doi.org/10.2478/acph-2014-0022
MLA 8th Edition
MUSELIK, JAN, et al. "Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP." Acta Pharmaceutica, vol. 64, no. 3, 2014, pp. 355-367. https://doi.org/10.2478/acph-2014-0022. Accessed 17 Oct. 2019.
Chicago 17th Edition
MUSELIK, JAN, ALEŠ FRANC, PETR DOLEŽEL, ROMAN GONĚC, ANNA KRONDLOVÁ and IVANA LUKÁŠOVÁ. "Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP." Acta Pharmaceutica 64, no. 3 (2014): 355-367. https://doi.org/10.2478/acph-2014-0022
Harvard
MUSELIK, J., et al. (2014). 'Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP', Acta Pharmaceutica, 64(3), pp. 355-367. https://doi.org/10.2478/acph-2014-0022
Vancouver
MUSELIK J, FRANC A, DOLEŽEL P, GONĚC R, KRONDLOVÁ A, LUKÁŠOVÁ I. Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP. Acta Pharm. [Internet]. 2014 [cited 2019 October 17];64(3):355-367. https://doi.org/10.2478/acph-2014-0022
IEEE
J. MUSELIK, A. FRANC, P. DOLEŽEL, R. GONĚC, A. KRONDLOVÁ and I. LUKÁŠOVÁ, "Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP", Acta Pharmaceutica, vol.64, no. 3, pp. 355-367, 2014. [Online]. https://doi.org/10.2478/acph-2014-0022

Abstracts
The article describes the development and production of tablets using direct compression of powder mixtures. The aim was to describe the impact of filler particle size and the time of lubricant addition during mixing on content uniformity according to the Good Manufacturing Practice (GMP) process validation requirements. Processes are regulated by complex directives, forcing the producers to validate, using sophisticated methods, the content uniformity of intermediates as well as final products. Cutting down of production time and material, shortening of analyses, and fast and reliable statistic evaluation of results can reduce the final price without affecting product quality. The manufacturing process of directly compressed tablets containing the low dose active pharmaceutical ingredient (API) warfarin, with content uniformity passing validation criteria, is used as a model example. Statistic methods have proved that the manufacturing process is reproducible. Methods suitable for elucidation of various properties of the final blend, e.g., measurement of electrostatic charge by Faraday pail and evaluation of mutual influences of researched variables by partial least square (PLS) regression, were used. Using these methods, it was proved that the filler with higher particle size increased the content uniformity of both blends and the ensuing tablets. Addition of the lubricant, magnesium stearate, during the blending process improved the content uniformity of blends containing the filler with larger particles. This seems to be caused by reduced sampling error due to the suppression of electrostatic charge.

Keywords
content uniformity; warfarin; validation; narrow therapeutic index; Faraday pail; PLS regression

Hrčak ID: 121066

URI
https://hrcak.srce.hr/121066

Visits: 7.028 *